UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E

Emerging infectious diseases, 2015-11, Vol.21 (11), p.1928-1934

2015

Volltextzugriff (PDF)

Letter: nutritional benefits of rifaximin in cirrhotic patients

Alimentary Pharmacology & Therapeutics (Suppl), 2018-03, Vol.47 (5), p.699-700

2018

Volltextzugriff (PDF)

Letter: liver transplantation for acute HEV infection in cirrhotic patients in France

Alimentary pharmacology & therapeutics, 2017-08, Vol.46 (4), p.477-478

2017

Volltextzugriff (PDF)

Detection of rare hepatitis C viruses of subtype 4r in Southeastern France

Clinical microbiology and infection, 2017-07, Vol.23 (7), p.493-495

2017

Volltextzugriff (PDF)

A national survey of acute hepatitis E in France

Alimentary pharmacology & therapeutics, 2008-06, Vol.27 (11), p.1086-1093

2008

Volltextzugriff (PDF)

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies

Journal of viral hepatitis, 2006-10, Vol.13 (10), p.659-670

2006

Volltextzugriff (PDF)

Comparison of modified (m)RECISTand RECIST 1.1 assessments in the phase 3 RESORCE trial comparing regorafenib and placebo in patients with hepatocellular carcinoma who progressed during sorafenib treatment

Journal of hepatology, 2017, Vol.66 (1), p.S451-S452

2017

Volltextzugriff (PDF)

Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy; an international retrospective comparative cohort study

Journal of hepatology, 2017, Vol.66 (1), p.S59-S59

2017

Volltextzugriff (PDF)

Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer

Journal of viral hepatitis, 2010-11, Vol.17 (11), p.807-815

2010

Volltextzugriff (PDF)

Expensiveness of hepatitis C virus polymerase inhibitor sofosbuvir: a warrant for therapeutic drug monitoring of compliance

Clinical microbiology and infection, 2015-04, Vol.21 (4), p.e32-e32

2015

Volltextzugriff (PDF)

Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection

Clinical microbiology and infection, 2008-12, Vol.14 (12), p.1176-1180

2008

Volltextzugriff (PDF)

Acute and chronic hepatitis E in patients infected with human immunodeficiency virus

Journal of viral hepatitis, 2011-03, Vol.18 (3), p.227-228

2011

Volltextzugriff (PDF)

1021 GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA (HCC) AND OF ITS TREATMENT WITH SORAFENIB (GIDEON): IMPACT OF LIVER DYSFUNCTION ON SORAFENIB TREATMENT IN EUROPE

Journal of hepatology, 2012-04, Vol.56, p.S399-S400

2012

Volltextzugriff (PDF)

1034 REAL-WORLD MANAGEMENT OF HCC WITH SORAFENIB AND TACE IN EUROPE FROM GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB)

Journal of hepatology, 2012-04, Vol.56, p.S404-S405

2012

Volltextzugriff (PDF)

370 HBV REACTIVATION FOLLOWING CHEMOTHERAPY IN HBSAG NEGATIVE / HBCAB POSITIVE PATIENTS IS ASSOCIATED WITH NON-A GENOTYPE AND THE EMERGENCE OF HBSAG MUTANTS

Journal of hepatology, 2011-03, Vol.54, p.S149-S149

2011

Volltextzugriff (PDF)

The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement

Diagnostic and interventional imaging, 2016-06, Vol.97 (6), p.643-650

2016

Volltextzugriff (PDF)

Fulminant Hepatitis B Associated with a Specific Insertion in the Basal Core Promoter Region of Hepatitis B Virus DNA after Immunosuppressive Treatment

Clinical infectious diseases, 2005-02, Vol.40 (4), p.e24-e27

2005

Volltextzugriff (PDF)

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

The New England journal of medicine, 2020-05, Vol.382 (20), p.1894-1905

2020

Volltextzugriff (PDF)

686 STRONG DECREASE OF ANTI-HEPATITIS B SURFACE ANTIGEN ANTIBODIES FOLLOWING RENAL TRANSPLANTATION

Journal of hepatology, 2008, Vol.48, p.S255-S256

2008

Volltextzugriff (PDF)

1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study

Annals of oncology, 2020-09, Vol.31, p.S699-S700

2020

Volltextzugriff (PDF)

Endoscopic Drainage of Pancreatic Pseudocysts Guided by Endosonography

Endoscopy, 1997-02, Vol.29 (2), p.106-108

1997

Volltextzugriff (PDF)

186 VIROLOGICAL AND CLINICAL SETTINGS ASSOCIATED WITH HBV SEROREVERSION AND REACTIVATION IN HIV-1 INFECTED PATIENTS IN SOUTH-EASTERN FRANCE

Journal of hepatology, 2008, Vol.48, p.S78-S79

2008

Volltextzugriff (PDF)

[145] AUTOCHTHONOUS AND TRAVEL-RELATED HEPATITIS E CASES IN MARSEILLES, FRANCE

Journal of hepatology, 2007, Vol.46, p.S65-S65

2007

Volltextzugriff (PDF)

[349] DIFFERENTIAL EFFECTS OF CONTROLLED PREOPERATIVE HEPATIC INFLAMMATORY RESPONSE ON LIVER REGENERATION AFTER PARTIAL HEPATECTOMY

Journal of hepatology, 2007, Vol.46, p.S136-S137

2007

Volltextzugriff (PDF)

Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients

Arthritis research & therapy, 2009-01, Vol.11 (6), p.R179-R179, Article R179

2009

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E

Letter: nutritional benefits of rifaximin in cirrhotic patients

Letter: liver transplantation for acute HEV infection in cirrhotic patients in France

Detection of rare hepatitis C viruses of subtype 4r in Southeastern France

A national survey of acute hepatitis E in France

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies

Comparison of modified (m)RECISTand RECIST 1.1 assessments in the phase 3 RESORCE trial comparing regorafenib and placebo in patients with hepatocellular carcinoma who progressed during sorafenib treatment

Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy; an international retrospective comparative cohort study

Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer

Expensiveness of hepatitis C virus polymerase inhibitor sofosbuvir: a warrant for therapeutic drug monitoring of compliance

Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection

Acute and chronic hepatitis E in patients infected with human immunodeficiency virus

1021 GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA (HCC) AND OF ITS TREATMENT WITH SORAFENIB (GIDEON): IMPACT OF LIVER DYSFUNCTION ON SORAFENIB TREATMENT IN EUROPE

1034 REAL-WORLD MANAGEMENT OF HCC WITH SORAFENIB AND TACE IN EUROPE FROM GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB)

370 HBV REACTIVATION FOLLOWING CHEMOTHERAPY IN HBSAG NEGATIVE / HBCAB POSITIVE PATIENTS IS ASSOCIATED WITH NON-A GENOTYPE AND THE EMERGENCE OF HBSAG MUTANTS

The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement

Fulminant Hepatitis B Associated with a Specific Insertion in the Basal Core Promoter Region of Hepatitis B Virus DNA after Immunosuppressive Treatment

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

686 STRONG DECREASE OF ANTI-HEPATITIS B SURFACE ANTIGEN ANTIBODIES FOLLOWING RENAL TRANSPLANTATION

1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study

Endoscopic Drainage of Pancreatic Pseudocysts Guided by Endosonography

186 VIROLOGICAL AND CLINICAL SETTINGS ASSOCIATED WITH HBV SEROREVERSION AND REACTIVATION IN HIV-1 INFECTED PATIENTS IN SOUTH-EASTERN FRANCE

[145] AUTOCHTHONOUS AND TRAVEL-RELATED HEPATITIS E CASES IN MARSEILLES, FRANCE

[349] DIFFERENTIAL EFFECTS OF CONTROLLED PREOPERATIVE HEPATIC INFLAMMATORY RESPONSE ON LIVER REGENERATION AFTER PARTIAL HEPATECTOMY

Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients

Suchergebnisse filtern